Kyriaki Barmpa
PhD Candidate, Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg
"By collaborating with Sciomics, we conducted a detailed analysis of the proteome of striatum organoids, uncovering significant differences that further assisted our research. Their communication was highly efficient, and the results were delivered promptly."
Product: scioPhospho
Dr. Matthew Wright
Chief Scientific Officer, Kinarus Therapeutics AG, Basel, Switzerland
"We are a small biotech company without our own wet labs. Sciomics recommended a UK CRO that performed cell culture experiments for our studies. Sciomics seamlessly coordinated the transfer of the biologic materials to their facility and performed the scioCD panel to characterize cell surface markers and cytokines in cell lines treated with our small molecule drug candidates. The Sciomics data were instrumental in supporting our IP protection strategy. Their advice was very helpful and they worked with us to extract the most out of the data. We are very satisfied and highly recommend the Sciomics platform and the team."
Product: scioCD
Dr. Bettina Grötsch
Department of Medicine 3 - Rheumatology and Immunology, University Clinics Erlangen, Erlangen, Germany
"Our lab is working with human osteoclast that were isolated and differentiated from human peripheral blood. Therefore, we were quite limited in cell numbers and protein content for our planned Phosphoprotein analyses. Nonetheless, Sciomics and especially Camille Lowy helped us a lot to test and improve our protein isolation techniques to achieve some interesting phosphoproteome data in human osteoclasts. We were really impressed by the detailed data report and their willingness to discuss and reanalyze the data repeatedly until we got the best results out of our measurements. Even several month after their first report, we could ask for help and suggestions with an immediate reply. The phosphoproteome analyses completed our preliminary project data and are now published in Frontiers Immunology. Altogether, we were very happy with the service of Sciomics and special thanks to Camille Lowy and Christoph Schröder who guided us through the whole process."
Product: scioPhospho
Publication: Grötsch B. et al. 2022 Front. Immunol. 13:958974
Alenka Djarmila Behsen, PhD candidate
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
"The process of working with Ronny and his colleagues at Sciomics has been very easy and efficient. Response time is very quick and they are always available for meetings when you have more questions. Would definitely recommend working with Sciomics."
Product: scioCD
Dr. Joachim Lupberger
Institute for Viral and Liver Disease, Inserm U1110, University of Strasbourg, LabEx HepSYS, Strasbourg, France
"Our lab is focusing on the identification of minimal-invasive biomarkers for liver disease progression. A challenge of our humanized animal models for liver disease is the low volume of blood samples available, which did not pose any problem for the analysis. I was pleased by the prompt, friendly, and uncomplicated contact and was impressed by the results and the thorough report we received. The overall quality was excellent, which made us to continue using the service of Sciomics for follow-up projects analyzing patient material."
Product: scioPhospho
Dr. Annett Böddrich
Max Delbrück Center for Molecular Medicine, Department of Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Berlin, Germany
"We were very satisfied with the service from Sciomics. Using the ScioDiscover antibody microarray on our biosamples, Sciomics identified genes differentially expressed in Alzheimer’s disease models. From the beginning, they engaged in detailed discussions with us to design the best possible project plan. Because we had only small amounts of material, they went to great lengths to adapt their protocols to our needs. They took a lot of time to answer all our questions and discuss the resulting data. I really can recommend Sciomics. "
Service: scioPhospho protein and phosphorylation profiling service
Dr. Felix Czernilofsky
Department of Medicine V, Heidelberg University Hospital,Heidelberg, Germany
"The scioCyto assay from Sciomics was a tremendous help in characterizing complex supernatants of in vitro tumor microenvironment models. With the professional, fast and friendly support from Ronny and colleagues we were able to confirm and extend our hypotheses. I am very happy to recommend the Sciomics experience!"
Product: scioCyto
Prof. Dr. Andreas Weigert
Goethe-University Frankfurt, Faculty of Medicine, Institute of Biochemistry I, Frankfurt, Germany
"We were under considerable time pressure to gain comprehensive information about cytokine/chemokine levels in a mouse model of self-resolving inflammation. To add to our misery, we had only a small number of biological replicates to run the analyses. Thankfully, the team at Sciomics were able to come to our rescue by providing a very prompt analysis, without neglecting to properly communicate the procedure, potential caveats and other details. The whole process was a very satisfying experience, rather like working with committed colleagues than with a company, and we got great data out of the project. I do happily recommend working with Sciomics for targeted proteomics analyses."
Product: scioCD
Dr. Bhavani Kowtharapu
Rostock University Medical Center, Department of Ophthalmology, Rostock, Germany
"I am really happy with service of Sciomics. Very friendly team and really fast service and we have the results in our hand including bioinformatics analysis within 2 weeks. Thank you Sciomics team."
Product: scioCD protein profiling service
Publication: Int. J. Mol. Sci. 2018, 19(2), 464
Dr. Anke König
Clinics for dermatology, venerology and allergology, University Clinics Frankfurt, Frankfurt, Germany
"We enjoyed working with Sciomics on various research projects related to inflammatory skin diseases. The cooperation with Sciomics was just excellent. In addition to processing the samples and compiling the data in a perfectly understandable way, Sciomics GmbH supports us with the entire interpretation and presentation of our results with lots of ideas beyond the usual level of corporate performance. We are looking forward to developing new ideas for further clinical studies together."
Product: scioDiscover
apl. Prof. Dr. rer. nat. Andreas H. Wagner
University Heidelberg, Medical Faculty, Institute of Physiologie and Pathophysiology, Division of Cardiovascular Physiology, Heidelberg, Germany
"We used scioDiscover for differential protein expression profiling in a mouse model with enhanced aortic aneurysm severity to identify target proteins in the aorta after medical therapy. Even with a very small amount of tissue below 10 mg, the quality of sample preparation and the data we obtained was exceptional. The support and advice was professional, very helpful, and very friendly. We are overall very satisfied with the results and the Sciomics team! "
Product: scioDiscover
Prof. Dr. Markus Gräler
University Hospital Jena, SG Sepsis Research, Department of Anaesthesiology and Intensive Care Medicine, Germany
"Working with Sciomics on a project was a very pleasant experience. Sciomics did everything we requested including analysis, re-analysis and re-re-analysis. They provided us with raw data, answered all our questions and gave us a detailed picture of the background procedures of their methods. We were very satisfied with their service and absolutely recommend them to everyone interested in their antibody array service."
Product: scioCD protein profiling service
Dr. Leonardo Guasti
Centre for Endocrinology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
"We were satisfied with the service provided by Sciomics back in 2017, so when it came to study a newly discovered secreted protein, for which little biology is known, we decided to engage again with them. Indeed, the phosphorylation and protein expression level data provided by Sciomics was of great help in assessing modulation of pathways initiated by adrenal cortex cells treated with this protein. Crucially, the Sciomics team actively engaged with us during both the planning of the experiments and subsequently in data analysis. This comprehensive data set has truly put us in the right path to dig into the role of a newly discovered protein in adrenocortical pathobiology."
Product: scioPhospho
Prof. Claudio Mauro
Birmingham University, Institute of Inflammation and Ageing, Birmingham, UK
"We have performed an acetylation array on primary T lymphocytes with Sciomics. The quality of the data we have obtained is exceptional. They have a model of collaboration with the team conducting the experiment. This means they generate the data and assist with further analyses of the data. The screening has opened up several exciting ways forward for us."
Product: scioAcetyl protein and protein acetylation profiling service (under co-development with selected partners)
Dr. Clarissa von Haefen
Charité University Clinics, Berlin, Germany
"Ich fühle mich sehr gut beraten und bin mit dem Service der Firma außerordentlich zufrieden. Ich kann meine Forschung, dank der Ergebnisse, in neue Richtungen lenken und hoffe sehr, dass dieses in einen erfolgreichen Antrag mündet. Vielen lieben Dank für die gute Zusammenarbeit."
Product: scioCD protein profiling service
| September 2023 | New Article: Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia. Sciomics supported this study by scioCyto serum analysis in a mouse cancer model.
| July 2023 | New Article: Fiedler et al. developed a novel methodology for vitamin B6 diagnostics. We supported the project by the production of custom antibody microarray targeting signature human PLP-DE and testing respective samples.
| February 2023 | New Article: In the study Tintelnot et al. identified a microbiota-derived metabolite that has clinical implications in the treatment of pancreatic cancer. Sciomics supported the authors by a protein profiling study of tumours derived from a mouse model upon treatment with 3-IAA and Firinox.
| April 2023 | New Article: In a protein biomarker development project initiated by Sciomics, we have identified protein biomarker panels predicting development of a severe Covid.19 disease.
At Sciomics, we are dedicated to advancing healthcare through proteomics research. We are collaborating with research groups and big pharma, alongside our in-house biomarker research initiatives. To make this research more accessible to you, we are launching the new Sciomics science blog!
The first study we will feature was published this year in a journal in the Nature publishing group. It's a topic that affects us all. Any guesses? Stay tuned!
Dr. Matthew Wright
Chief Scientific Officer, Kinarus Therapeutics AG, Basel, Switzerland
"We are a small biotech company without our own wet labs. Sciomics recommended a UK CRO that performed cell culture experiments for our studies. Sciomics seamlessly coordinated the transfer of the biologic materials to their facility and performed the scioCD panel to characterize cell surface markers and cytokines in cell lines treated with our small molecule drug candidates. The Sciomics data were instrumental in supporting our IP protection strategy. Their advice was very helpful and they worked with us to extract the most out of the data. We are very satisfied and highly recommend the Sciomics platform and the team."
Product: scioCD
Kyriaki Barmpa
PhD Candidate, Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg
"By collaborating with Sciomics, we conducted a detailed analysis of the proteome of striatum organoids, uncovering significant differences that further assisted our research. Their communication was highly efficient, and the results were delivered promptly."
Product: scioPhospho